Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis

Journal: Nature

Published: 2019-12-18

DOI: 10.1038/s41586-019-1856-1

Affiliations: 25

Authors: 54

Go to article
Institutions Share
Department of Pathology and Tumor Biology, Kyoto University, Japan 0.21
Department of Gastroenterology and Hepatology, Kyoto University, Japan 0.12
WPI Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Japan 0.10
Faculty / Graduate School of Medicine, Kyoto University, Japan 0.07
Sumitomo Dainippon Pharma Co., Ltd., Japan 0.05
Department of Diagnostic Pathology, Kyoto University, Japan 0.05
Laboratory of DNA Information Analysis, UTokyo, Japan 0.05
Research and Development Center for Precision Medicine (PMC), University of Tsukuba, Japan 0.04
Department of Inflammatory Bowel Disease, Hyogo College of Medicine, Japan 0.04
School of Medicine, Hyogo College of Medicine, Japan 0.04
Department of Medical Chemistry, Kyoto University, Japan 0.04
Division of Experimental Therapeutics, Kyoto University, Japan 0.04
Department of Therapeutic Oncology, Kyoto University, Japan 0.03
Laboratory of Sequence Analysis, UTokyo, Japan 0.03
Department of Immunology, Akita University, Japan 0.02
Division of Molecular Oncology, NCC, Japan 0.02
Cancer Institute Hospital, JFCR, Japan 0.02
Department of Advanced Diagnosis, Nagoya Medical Center, Japan 0.01
Faculty of Medicine, Kyorin University, Japan 0.01
School of Medicine, Kanazawa Medical University, Japan 0.01
Sapporo Medical University School of Medicine, Japan 0.01
Kansai Electric Power Hospital, Japan 0.01
Center for Hematology and Regenerative Medicine (HERM), KI, Sweden 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER